Table 4.
No. | Age Range (yrs) | Follow-up (yrs) | AMD Status | HR of CHD (95% CI)a | HR of Stroke (95% CI)a | |
---|---|---|---|---|---|---|
US Medicare data35 | 1,445,677 | ≥65 | 2 | Late | 1.19 (1.16–1.22) | — |
US Medicare data43 | 1,303,186 | ≥65 | 2 | Late | — | 1.21 (1.18–1.23) |
ARIC Study18,19 | 10,000+ | 51–72 | 10 | Early | 1.08 (0.82–1.42) | 1.85 (1.19–2.87) |
Late | 3.10 (1.15–8.31) | — | ||||
Blue Mountains Eye Study20 | 3654 | ≥49 | 11 | Early | 2.32 (1.03–5.19)b | — |
Late | 5.57 (1.35–22.99)b,c | 10.2 (2.39–43.6)b,c | ||||
Beaver Dam Eye Study21 | 4926 | 43–84 | 14 | Early or late | 0.95 (0.87–1.07) | 0.97 (0.75–1.23) |
Cardiovascular Health Study | 1786 | 69–97 | 7 | Early | 1.57 (1.17–2.22) | 1.05 (0.69–1.58) |
Late | 0.78 (0.25–2.48) | 1.43 (0.45–4.54) |
AMD = age-related macular degeneration; CHD = coronary heart disease; ARIC = Atherosclerosis In Community Study; HR = hazard ratio; CI = confidence interval.
Multivariable hazard ratios of CHD or stroke (CHD or stroke mortality for the Blue Mountains Eye Study and Beaver Dam Eye Study).
Only in persons aged < 75 yrs.
Age and gender adjusted only.